Immune Checkpoint Inhibitors
Drugs that block negative regulator IMMUNE CHECKPOINT proteins (e.g., PD-1 RECEPTOR and CTLA-4 ANTIGEN) thereby increasing suppressed immune activation in immunotherapies.
推出的年份: 2021
树号: D27.505.519.507, D27.505.954.248.384.500
MeSH 单一 ID: D000082082
进入的组:
- Checkpoint Inhibitors, Immune
- Immune Checkpoint Inhibitor
- Checkpoint Inhibitor, Immune
- Immune Checkpoint Blockers
- Checkpoint Blockers, Immune
- Immune Checkpoint Blockade
- Checkpoint Blockade, Immune
- Immune Checkpoint Inhibition
- Checkpoint Inhibition, Immune
- PD-L1 Inhibitors
- PD L1 Inhibitors
- PD-L1 Inhibitor
- PD L1 Inhibitor
- Programmed Death-Ligand 1 Inhibitors
- Programmed Death Ligand 1 Inhibitors
- PD-1-PD-L1 Blockade
- Blockade, PD-1-PD-L1
- PD 1 PD L1 Blockade
- CTLA-4 Inhibitors
- CTLA 4 Inhibitors
- CTLA-4 Inhibitor
- CTLA 4 Inhibitor
- Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitors
- Cytotoxic T Lymphocyte Associated Protein 4 Inhibitors
- Cytotoxic T-Lymphocyte-Associated Protein 4 Inhibitor
- Cytotoxic T Lymphocyte Associated Protein 4 Inhibitor
- PD-1 Inhibitors
- PD 1 Inhibitors
- PD-1 Inhibitor
- Inhibitor, PD-1
- PD 1 Inhibitor
- Programmed Cell Death Protein 1 Inhibitor
- Programmed Cell Death Protein 1 Inhibitors
早前的内容:
- Antineoplastic Agents (2017-2020)
留言 (0)